Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia
Clinical trial NCT05325645 · RECRUITING
Trial details
- NCT number
- NCT05325645
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-21
- Primary completion
- 2026-02-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.